Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like mPoS devices to soon have sound-based contactless payment option June 14, 2017 H2W Technologies introduces VCS06-010-BS-01-MXY voice coil driven, XY positioning stage March 20, 2019 Mencom Corporation introduces Low-Profile Housings for Panel Interface Connectors November 8, 2017
H2W Technologies introduces VCS06-010-BS-01-MXY voice coil driven, XY positioning stage March 20, 2019